NIEUWEGEIN, The Netherlands, February 14 /PRNewswire/ -- In the news release, "Ballast Nedam: New Order for 170 Million Euros" issued on 14 Feb 2008 08:13 GMT, by Ballast Nedam NV AEX:BALN over PR Newswire, we are advised by a representative of the company that there have been revisions to the 1st paragraph. In the 2nd line, the text "multi-fuel power plant Nuon Magnum IGCC" has been changed to "gasfired part of the Nuon Magnum power plant". Further along, the place name "Eemshaven" has also been added so the text reads "Eemshaven, Groningen, The Netherlands." Complete, corrected release follows:

PARIS, February 14 /PRNewswire/ --

- GenOdyssee has Received Notice of Allowance of United States Patent Application Covering it's Lead HCV Interferon-Alpha Product GEA007.1, a Natural Protein With Improved Anti-HCV Genotype 1 Activity

LONDON, February 14 /PRNewswire/ -- Saipem S.A and investment partnerships affiliated with Hellman & Friedman LLC ("H&F"), executed a definitive agreement under which H&F will acquire Saipem's 30% ownership stake in Gaztransport & Technigaz S.A.S. ("GTT") for EUR310 million. GTT is the leading marine engineering company operating in the liquefied natural gas ("LNG") sector and is based near Paris in Saint-Remy-les-Chevreuse and has over 200 employees.

PARIS, February 14 /PRNewswire/ -- Sanofi-aventis announced today that the Chicago Athenaeum Museum of Architecture and Design has awarded a 2007 GOOD DESIGN(TM) Award for the new SoloSTAR(R) disposable insulin injection pen for people with type 1 and type 2 diabetes.

"LANTUS(R) SoloSTAR(R) and APIDRA(R) SoloSTAR(R), the results of over four years of intensive development, have been designed in dialogue with patients, nurses and doctors and meet the high standards of the industry," said Paul Jansen, Global Head Medical Devices, sanofi-aventis.

"We are proud to receive this prestigious GOOD DESIGN Award for SoloSTAR(R) as a recognition of our strong commitment to people with diabetes", Gilles Lhernould, Senior Vice President Industrial Affairs sanofi-aventis added.

ARNHEM, The Netherlands, February 14 /PRNewswire/ -- The 23rd Annual Congress of the European Association of Urology will be held from 26-29 March 2008 in Milan, Italy. About 12,000 participants from some 100 different countries are expected to attend, which makes this event the second largest of its kind worldwide. And as media representative you cannot miss out. Why not? Please read on.

Scientific content

HEIDELBERG, Germany, February 14 /PRNewswire/ -- SYGNIS Pharma AG (Frankfurt: LIO; ISIN DE0005043509; Prime Standard), today announced that it has received a positive recommendation from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMEA) for AX200 for the treatment of Amyotrophic Lateral Sclerosis (ALS).